System1 Biosciences

About:

System1 Biosciences is a neurotherapeutics company.

Website: https://system1.bio/

Top Investors: CRV, Liquid 2 Ventures, Alexandria Venture Investments, Pfizer Venture Investments, Riot Ventures

Description:

System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. System1 combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. These “deep phenotypes” are exploited to identify novel therapeutic targets and drug treatments.

Total Funding Amount:

$25M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-01-01

Founders:

Frederic Kerrest, Saul Kato, Sean Escola

Number of Employees:

11-50

Last Funding Date:

2018-09-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai